Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension
Study sponsor: Mineralys Therapeutics Inc. · MLYS
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-09-07Actual
Enrollment · participants200Actual
Source updated2024-01-05Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.